arrow
S

Silvia Montoto

IRCCS Ospedale San Raffaele
H指数:62
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee

出版商更正:定义造血移植和细胞治疗领域的全球优先事项:EBMT全球委员会的一份声明文件

2026-10-120
OAAI
Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global ComMittee

定义全球造血移植和细胞治疗的优先事项:EBMT全球委员会声明文件

2026-08-110
OAAI
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study

免疫缺陷相关性原发性中枢神经系统淋巴瘤:一项国际原发性中枢神经系统淋巴瘤协作组(IPPC)研究

Blood
IF23.1
2026-03-200
OAAI
Transient imaging changes accompany ‘spinal ICANS’ following CAR T-cell therapy for large B-cell lymphoma in adults

成人接受大B细胞淋巴瘤CAR T细胞治疗后,‘spinal ICANS’伴随一过性影像学改变。

2025-10-130
OAAI
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.

异基因造血干细胞移植在免疫检查点抑制剂时代霍奇金淋巴瘤中的疗效:CIBMTR与EBMT联合分析。

Blood
IF23.1
2025-07-090
PRE
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024-09-030
OAAI
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation

滤泡性淋巴瘤的造血细胞移植和细胞治疗的临床实践建议: 代表美国移植和细胞治疗学会和欧洲血液和骨髓移植学会的合作努力

2024-09-012
OAAI
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years
2024-07-051
OAAI
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
LEUKEMIA
IF13.4
2022-12-226
PRE
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
2022-10-046
OAAI
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
2022-09-155
PRE
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years (vol 36, pg I646, 2022)
LEUKEMIA
IF13.4
2022-07-150
OA
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

多发性骨髓瘤自体干细胞移植的并发症: CALM研究的结果

2022-06-208
OAAI
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
LEUKEMIA
IF13.4
2022-04-128
PRE
Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma
2021-11-017
PREAI
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
2021-07-2027
OA
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

异基因造血干细胞移植治疗恶性血液病后移植物抗宿主病患者预后的改善: 一项EBMT mega-file研究

2021-06-2441
OAAI